Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
17.88
-0.32 (-1.76%)
Nov 21, 2024, 11:57 AM EST - Market open
Aligos Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$75.00
Upside
+319.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +319.46% | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +319.46% | Oct 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +319.46% | Sep 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $75 | Strong Buy | Initiates | $75 | +319.46% | Aug 19, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $75 → $175 | Buy | Maintains | $75 → $175 | +878.75% | Jan 17, 2023 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $50 → $75 | Hold → Buy | Upgrades | $50 → $75 | +319.46% | Jan 6, 2023 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $63 → $75 | Hold → Strong Buy | Upgrades | $63 → $75 | +319.46% | Jan 6, 2023 |
| SVB Leerink | SVB Leerink | Hold Maintains $75 → $50 | Hold | Maintains | $75 → $50 | +179.64% | Nov 3, 2022 |
| SVB Leerink | SVB Leerink | Buy → Hold Downgrades $175 → $75 | Buy → Hold | Downgrades | $175 → $75 | +319.46% | May 5, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $275 → $175 | Buy | Maintains | $275 → $175 | +878.75% | Mar 23, 2022 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $375 → $100 | Buy → Hold | Downgrades | $375 → $100 | +459.28% | Mar 23, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $1,175 → $375 | Buy | Maintains | $1,175 → $375 | +1,997.32% | Mar 11, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $250 → $275 | Buy | Maintains | $250 → $275 | +1,438.03% | Mar 11, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $375 → $250 | Buy | Maintains | $375 → $250 | +1,298.21% | Feb 16, 2022 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $750 → $300 | Buy → Hold | Downgrades | $750 → $300 | +1,577.85% | Jan 7, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $725 → $375 | Buy | Maintains | $725 → $375 | +1,997.32% | Jan 7, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.